% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Gelfert:280976,
author = {Gelfert, Gloria G and Grittner, Ulrike and Kuhnert, Ronny
and Scheidt-Nave, Christa and Endres, Matthias and Nave,
Alexander H},
title = {{A}ssociation of {L}ipoprotein(a) {W}ith {C}ardiovascular
and {C}erebrovascular {D}isease in a {N}ationally
{R}epresentative {C}ohort of {G}ermany.},
journal = {JACC: advances},
volume = {4},
number = {8},
issn = {2772-963X},
address = {[Amsterdam]},
publisher = {Elsevier B.V.},
reportid = {DZNE-2025-01058},
pages = {102015},
year = {2025},
abstract = {Population-based data on the distribution of lipoprotein(a)
(Lp[a]) within the German population are lacking.The aim of
the study was to determine the age- and sex-specific Lp(a)
distribution in Germany and analyze its association with
different types of cardiovascular disease (CVD).We analyzed
cross-sectional data from the German National Health
Interview and Examination Survey 1998, a population-based
study representing the German adult population's health
status from 1997 to 1999. We examined serum Lp(a) according
to demographics and investigated associations between Lp(a)
and history of self-reported CVD. We tested Lp(a) in spline
analysis on continuous scales and as dichotomous Lp(a)
thresholds.In the German National Health Interview and
Examination Survey 1998 (n = 6,657), median Lp(a) was 15.3
mg/dL (Q1-Q3: 5.6, 43.1). Lp(a) levels ≥50 mg/dL were
present in $21.6\%.$ Men had substantially higher median
Lp(a) than women (22.1 mg/dL vs 10.3 mg/dL). Median Lp(a)
levels were significantly higher in individuals with than
without a history of atherosclerotic cardiovascular disease
(ASCVD) but did not significantly differ between people with
and without venous thrombosis. In logistic regression
analysis with splines, higher Lp(a) levels were associated
with a higher probability of a history of CVD. In logistic
regression analyses, Lp(a) ≥50 mg/dL was associated with a
history of ASCVD (OR: 1.36 $[95\%$ CI: 1.04-1.78]; P =
0.023).About 1 in 5 German individuals from a prestatin era
population had Lp(a) levels ≥50 mg/dL. Higher levels were
independently associated with ASCVD, but not with venous
thrombosis. These findings provide a basis for future
prospective studies to define the role of Lp(a) in CVD risk
in the German population.},
keywords = {cardiovascular disease (Other) / cardiovascular risk
(Other) / epidemiology (Other) / lipoprotein(a) (Other) /
prevention (Other) / venous thrombosis (Other)},
cin = {AG Endres},
ddc = {610},
cid = {I:(DE-2719)1811005},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40706144},
pmc = {pmc:PMC12309279},
doi = {10.1016/j.jacadv.2025.102015},
url = {https://pub.dzne.de/record/280976},
}